Adicet Historical Income Statement

ACET Stock

USD 0.91 0.01 1.09%

Historical analysis of Adicet Bio income statement accounts such as Interest Expense of 27.3 K, Selling General Administrative of 34.7 M or Total Revenue of 0.0 can show how well Adicet Bio performed in making a profits. Evaluating Adicet Bio income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Adicet Bio's future profits or losses.

Cash Flow Balance Sheet Income Statement

Dot-com Bubble

Housing Crash

Credit Downgrade

Yuan Drop

Covid

Financial Statement Analysis is much more than just reviewing and examining Adicet Bio latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Adicet Bio is a good buy for the upcoming year.

Net Income Gross Profit

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Adicet Bio. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income.

For more information on how to buy Adicet Stock please use our How to Invest in Adicet Bio guide.

About Adicet Income Statement Analysis

Adicet Bio Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Adicet Bio shareholders. The income statement also shows Adicet investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).

Adicet Bio Income Statement Chart

At this time, Adicet Bio's Reconciled Depreciation is comparatively stable compared to the past year.

Selling General Administrative Other Operating Expenses Research Development Cost Of Revenue Total Other Income Expense Net

Other Operating Expenses

Other Operating Expenses is the expense which generally does not depend on sales or production quantities of Adicet Bio. It is also known as Adicet Bio overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.

Cost Of Revenue

Cost of Revenue is found on Adicet Bio income statement and represents the costs associated with goods and services Adicet Bio provides. Indirect cost, such as salaries, is not included. In other words, cost of revenue is the total cost incurred to obtain a sale. It is more than the traditional cost of goods sold, since it includes specific selling and marketing activities.

Most accounts from Adicet Bio's income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Adicet Bio current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Adicet Bio. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income.

For more information on how to buy Adicet Stock please use our How to Invest in Adicet Bio guide.At this time, Adicet Bio's Reconciled Depreciation is comparatively stable compared to the past year.

	2022	2023	2024	2025 (projected)
Interest Expense	80K	25K	28.8K	27.3K
Depreciation And Amortization	5.0M	6.1M	7.0M	5.2M

Interest Expense Depreciation And Amortization

Adicet Bio income statement Correlations

	Depreciation And Amortization	Interest Expense	Selling General Administrative	Total Revenue	Gross Profit	Other Operating Expenses	Operating Income	Ebit	Research Development	Ebitda	Cost Of Revenue	Total Operating Expenses	Income Before Tax	Total Other Income Expense Net	Net Income	Income Tax Expense	Selling And Marketing Expenses	Tax Provision	Net Interest Income	Interest Income	Net Income From Continuing Ops	Reconciled Depreciation
Depreciation And Amortization		0.07	0.38	0.33	-0.25	0.33	0.09	0.07	0.01	0.12	0.61	0.14	0.12	0.25	0.1	0.43	0.29	0.06	0.15	0.15	-0.13	0.14
Interest Expense	0.07		0.83	0.79	0.93	0.05	0.45	0.43	-0.47	0.43	0.36	-0.5	0.39	-0.82	0.4	0.81	0.7	-0.48	-0.37	-0.38	0.42	-0.39
Selling General Administrative	0.38	0.83		0.95	0.69	0.48	0.57	0.56	-0.49	0.58	0.74	-0.33	0.55	-0.62	0.52	0.92	0.91	-0.45	-0.3	-0.31	0.37	-0.32
Total Revenue	0.33	0.79	0.95		0.64	0.56	0.78	0.77	-0.71	0.78	0.84	-0.53	0.76	-0.66	0.74	0.87	0.98	-0.66	-0.52	-0.52	0.58	-0.53
Gross Profit	-0.25	0.93	0.69	0.64		-0.06	0.33	0.32	-0.37	0.3	0.11	-0.44	0.26	-0.85	0.27	0.67	0.57	-0.39	-0.32	-0.32	0.36	-0.33
Other Operating Expenses	0.33	0.05	0.48	0.56	-0.06		0.54	0.58	-0.36	0.59	0.76	0.07	0.57	0.02	0.51	0.34	0.63	-0.3	-0.15	-0.15	0.21	-0.17
Operating Income	0.09	0.45	0.57	0.78	0.33	0.54		1.0	-0.96	1.0	0.77	-0.78	1.0	-0.61	1.0	0.44	0.8	-0.88	-0.86	-0.86	0.92	-0.87
Ebit	0.07	0.43	0.56	0.77	0.32	0.58	1.0		-0.95	1.0	0.77	-0.75	1.0	-0.59	0.99	0.43	0.8	-0.87	-0.84	-0.84	0.9	-0.85
Research Development	0.01	-0.47	-0.49	-0.71	-0.37	-0.36	-0.96	-0.95		-0.95	-0.66	0.9	-0.95	0.69	-0.97	-0.38	-0.73	0.91	0.94	0.94	-0.95	0.95
Ebitda	0.12	0.43	0.58	0.78	0.3	0.59	1.0	1.0	-0.95		0.8	-0.74	1.0	-0.57	0.99	0.44	0.81	-0.87	-0.83	-0.83	0.89	-0.84
Cost Of Revenue	0.61	0.36	0.74	0.84	0.11	0.76	0.77	0.77	-0.66	0.8		-0.37	0.79	-0.26	0.76	0.65	0.87	-0.58	-0.44	-0.44	0.5	-0.46
Total Operating Expenses	0.14	-0.5	-0.33	-0.53	-0.44	0.07	-0.78	-0.75	0.9	-0.74	-0.37		-0.76	0.76	-0.8	-0.28	-0.51	0.82	0.92	0.92	-0.92	0.93
Income Before Tax	0.12	0.39	0.55	0.76	0.26	0.57	1.0	1.0	-0.95	1.0	0.79	-0.76		-0.55	1.0	0.41	0.78	-0.87	-0.84	-0.84	0.9	-0.86
Total Other Income Expense Net	0.25	-0.82	-0.62	-0.66	-0.85	0.02	-0.61	-0.59	0.69	-0.57	-0.26	0.76	-0.55		-0.58	-0.49	-0.61	0.59	0.74	0.74	-0.72	0.74
Net Income	0.1	0.4	0.52	0.74	0.27	0.51	1.0	0.99	-0.97	0.99	0.76	-0.8	1.0	-0.58		0.39	0.76	-0.88	-0.87	-0.87	0.93	-0.88
Income Tax Expense	0.43	0.81	0.92	0.87	0.67	0.34	0.44	0.43	-0.38	0.44	0.65	-0.28	0.41	-0.49	0.39		0.82	-0.41	-0.16	-0.16	0.23	-0.17
Selling And Marketing Expenses	0.29	0.7	0.91	0.98	0.57	0.63	0.8	0.8	-0.73	0.81	0.87	-0.51	0.78	-0.61	0.76	0.82		-0.68	-0.52	-0.52	0.59	-0.54
Tax Provision	0.06	-0.48	-0.45	-0.66	-0.39	-0.3	-0.88	-0.87	0.91	-0.87	-0.58	0.82	-0.87	0.59	-0.88	-0.41	-0.68		0.77	0.77	-0.87	0.8
Net Interest Income	0.15	-0.37	-0.3	-0.52	-0.32	-0.15	-0.86	-0.84	0.94	-0.83	-0.44	0.92	-0.84	0.74	-0.87	-0.16	-0.52	0.77		1.0	-0.96	1.0
Interest Income	0.15	-0.38	-0.31	-0.52	-0.32	-0.15	-0.86	-0.84	0.94	-0.83	-0.44	0.92	-0.84	0.74	-0.87	-0.16	-0.52	0.77	1.0		-0.96	1.0
Net Income From Continuing Ops	-0.13	0.42	0.37	0.58	0.36	0.21	0.92	0.9	-0.95	0.89	0.5	-0.92	0.9	-0.72	0.93	0.23	0.59	-0.87	-0.96	-0.96		-0.97
Reconciled Depreciation	0.14	-0.39	-0.32	-0.53	-0.33	-0.17	-0.87	-0.85	0.95	-0.84	-0.46	0.93	-0.86	0.74	-0.88	-0.17	-0.54	0.8	1.0	1.0	-0.97

Click cells to compare fundamentals

Adicet Bio Account Relationship Matchups

Adicet Bio income statement Accounts

	2020	2021	2022	2023	2024	2025 (projected)
Depreciation And Amortization	2.0M	4.1M	5.0M	6.1M	7.0M	5.2M
Selling General Administrative	22.8M	22.2M	26.3M	26.5M	23.9M	34.7M
Total Revenue	8.2M	995K	17.9M	9.7M	25.0M	0.0
Gross Profit	17.9M	9.7M	20.0M	(6.1M)	(5.5M)	(5.2M)
Other Operating Expenses	57.1M	71.2M	97.5M	152.0M	136.8M	182.5M
Operating Income	(39.2M)	(61.4M)	(72.6M)	(152.0M)	(136.8M)	(130.0M)
Ebit	(39.4M)	(64.5M)	(69.7M)	(142.6M)	(128.4M)	(122.0M)
Research Development	34.3M	48.9M	71.2M	106.0M	121.9M	128.0M
Ebitda	(37.4M)	(60.4M)	(64.7M)	(136.5M)	(122.9M)	(116.7M)
Cost Of Revenue	80K	125K	5.0M	6.1M	5.5M	5.2M
Total Operating Expenses	57.1M	71.2M	97.5M	152.0M	174.8M	183.6M
Income Before Tax	(39.5M)	(62.1M)	(69.8M)	(142.7M)	(128.4M)	(122.0M)
Total Other Income Expense Net	(302K)	(691K)	2.8M	9.4M	10.8M	11.3M
Net Income	(36.7M)	(62.0M)	(67.0M)	(142.7M)	(128.4M)	(122.0M)
Income Tax Expense	(2.8M)	(125K)	(2.8M)	5.9M	5.3M	5.6M

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for Adicet Stock Analysis

When running Adicet Bio's price analysis, check to measure Adicet Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Adicet Bio is operating at the current time. Most of Adicet Bio's value examination focuses on studying past and present price action to predict the probability of Adicet Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Adicet Bio's price. Additionally, you may evaluate how the addition of Adicet Bio to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Adicet Historical Income Statement

About Adicet Income Statement Analysis

Adicet Bio Income Statement Chart

Other Operating Expenses

Cost Of Revenue

Adicet Bio income statement Correlations

Adicet Bio Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Adicet Bio income statement Accounts

Thematic Opportunities

Explore Investment Opportunities

Additional Tools for Adicet Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Ebit	+ 1.0	Operating Income
Ebitda	+ 1.0	Operating Income
Income Before Tax	+ 1.0	Operating Income
Net Income	+ 1.0	Operating Income
Ebitda	+ 1.0	Ebit
Income Before Tax	+ 1.0	Ebit

Reconciled Depreciation	- 0.97	Net Income From Continuing Ops
Net Income	- 0.97	Research Development
Net Income From Continuing Ops	- 0.96	Interest Income
Net Income From Continuing Ops	- 0.96	Net Interest Income
Research Development	- 0.96	Operating Income
Net Income From Continuing Ops	- 0.95	Research Development